Literature DB >> 8408066

Intracellular retention of interleukin-6 abrogates signaling.

S Rose-John1, H Schooltink, H Schmitz-Van de Leur, J Müllberg, P C Heinrich, L Graeve.   

Abstract

Three forms of interleukin-6 (IL-6) have been constructed and stably transfected into human hepatoma cells (HepG2). Wild type IL-6 containing a signal peptide was rapidly secreted as a biologically active protein. IL-6 lacking the signal peptide accumulated within the cytoplasm of transfected cells. Surprisingly, IL-6 carrying a COOH-terminal extension of the amino acids Lys-Asp-Glu-Leu (KDEL) was not completely retained in the endoplasmic reticulum (ER). Complete retention in the ER was achieved when the 14 COOH-terminal amino acids of protein disulfide isomerase which include the KDEL signal were added to the COOH terminus of IL-6. This finding clearly demonstrates that the addition of the protein sorting signal KDEL alone is not sufficient for full retention of IL-6 in the ER. IL-6 accumulated in the cytoplasm and IL-6 retained in the ER failed to induce liver-specific acute-phase protein synthesis in the host cells, indicating that there is no intracellular role for IL-6 in signal transduction. Retention of IL-6 in the ER led to the prevention of surface expression of the IL-6 receptor protein gp80, making these cells unresponsive to IL-6. This phenomenon can be exploited in the future to generate transgenic animals which will become completely cytokine unresponsive in the tissues in which they express an ER retained cytokine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408066

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

2.  Endothelial cells direct mesenchymal stem cells toward a smooth muscle cell fate.

Authors:  Cho-Hao Lin; Brenda Lilly
Journal:  Stem Cells Dev       Date:  2014-07-14       Impact factor: 3.272

3.  Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.

Authors:  Louise Giffin; Feng Yan; M Ben Major; Blossom Damania
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display.

Authors:  Marina Kovaleva; Ingo Bussmeyer; Björn Rabe; Joachim Grötzinger; Enge Sudarman; Jutta Eichler; Udo Conrad; Stefan Rose-John; Jürgen Scheller
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

Review 6.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

7.  Promotion of Endoplasmic Reticulum-Associated Degradation of Procathepsin D by Human Herpesvirus 8-Encoded Viral Interleukin-6.

Authors:  Daming Chen; John Nicholas
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

8.  Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.

Authors:  A Kasza; K Rogowski; W Kilarski; R Sobota; T Bernas; J Dobrucki; J Travis; A Koj; M Bugno; T Kordula
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

9.  Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6.

Authors:  Daming Chen; Gordon Sandford; John Nicholas
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

10.  Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.

Authors:  Gang Wang; Li Pan; Yongguang Zhang; Yonglu Wang; Zhongwang Zhang; Jianliang Lü; Peng Zhou; Yuzhen Fang; Shoutian Jiang
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.